Biomarkers of neurohormonal activation, on-going myocardial damage, haemostasis and inflammation in patients with stable chronic heart failure due to left ventricular systolic dysfunction and potential novel treatment
The prognosis of patients with chronic heart failure (CHF) due to left ventricular systolic dysfunction (LVSD) remains poor despite the progress in modern therapy. Btype natriuretic peptide (BNP) is a useful diagnostic and most consistent prognostic markers in CHF. However, treatment strategy guided...
| Main Author: | |
|---|---|
| Published: |
University of Hull
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.638460 |